BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 28471166)

  • 1. Crocus sativus Extract Tightens the Blood-Brain Barrier, Reduces Amyloid β Load and Related Toxicity in 5XFAD Mice.
    Batarseh YS; Bharate SS; Kumar V; Kumar A; Vishwakarma RA; Bharate SB; Kaddoumi A
    ACS Chem Neurosci; 2017 Aug; 8(8):1756-1766. PubMed ID: 28471166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer's disease.
    Batarseh YS; Kaddoumi A
    J Nutr Biochem; 2018 May; 55():113-123. PubMed ID: 29413486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model.
    Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A
    ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal formation of trans-crocetin from saffron extract (Crocus sativus L.) and in vitro permeation through intestinal and blood brain barrier.
    Lautenschläger M; Sendker J; Hüwel S; Galla HJ; Brandt S; Düfer M; Riehemann K; Hensel A
    Phytomedicine; 2015 Jan; 22(1):36-44. PubMed ID: 25636868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents.
    Papandreou MA; Kanakis CD; Polissiou MG; Efthimiopoulos S; Cordopatis P; Margarity M; Lamari FN
    J Agric Food Chem; 2006 Nov; 54(23):8762-8. PubMed ID: 17090119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-β Clearance: In Vitro and In Vivo Studies.
    Elfakhri KH; Duong QV; Langley C; Depaula A; Mousa YM; Lebeouf T; Cain C; Kaddoumi A
    Neuroscience; 2018 May; 379():269-280. PubMed ID: 29596966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease.
    Finley JW; Gao S
    J Agric Food Chem; 2017 Feb; 65(5):1005-1020. PubMed ID: 28098452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
    Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
    Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saffron (Crocus sativus L.) extract attenuates chronic scopolamine-induced cognitive impairment, amyloid beta, and neurofibrillary tangles accumulation in rats.
    Patel KS; Dharamsi A; Priya M; Jain S; Mandal V; Girme A; Modi SJ; Hingorani L
    J Ethnopharmacol; 2024 May; 326():117898. PubMed ID: 38341114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
    Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
    Ardestani PM; Evans AK; Yi B; Nguyen T; Coutellier L; Shamloo M
    Neuropharmacology; 2017 Apr; 116():371-386. PubMed ID: 28089846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-faceted therapeutic strategy for treatment of Alzheimer's disease by concurrent administration of etodolac and α-tocopherol.
    Elfakhri KH; Abdallah IM; Brannen AD; Kaddoumi A
    Neurobiol Dis; 2019 May; 125():123-134. PubMed ID: 30710675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crocetin promotes clearance of amyloid-β by inducing autophagy via the STK11/LKB1-mediated AMPK pathway.
    Wani A; Al Rihani SB; Sharma A; Weadick B; Govindarajan R; Khan SU; Sharma PR; Dogra A; Nandi U; Reddy CN; Bharate SS; Singh G; Bharate SB; Vishwakarma RA; Kaddoumi A; Kumar A
    Autophagy; 2021 Nov; 17(11):3813-3832. PubMed ID: 33404280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
    Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
    J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
    Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis.
    Paganetti P; Antoniello K; Devraj K; Toni N; Kieran D; Madani R; Pihlgren M; Adolfsson O; Froestl W; Schrattenholz A; Liebner S; Havas D; Windisch M; Cirrito JR; Pfeifer A; Muhs A
    J Alzheimers Dis; 2014; 38(4):767-86. PubMed ID: 24072071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies.
    Abuznait AH; Qosa H; Busnena BA; El Sayed KA; Kaddoumi A
    ACS Chem Neurosci; 2013 Jun; 4(6):973-82. PubMed ID: 23414128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.